⌘K

Login Start Free

Home/Filings/4/0000921895-25-000087

4//SEC Filing

NATAN DAVID 4

Accession 0000921895-25-000087

CIK 0001130166other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 7:07 PM ET

Size

4.8 KB

Accession

0000921895-25-000087

Insider Transaction Report

Form 4

Period: 2025-01-02

Cyclacel Pharmaceuticals, Inc.CYCC

Director

Transactions

Award
Common Stock
2025-01-02+100,000→ 100,000 total

Footnotes (1)

[F1]Shares of restricted stock issued pursuant to a Director Agreement dated as of January 2, 2025 by and between Cyclacel Pharmaceuticals, Inc. and David Natan.

Documents

1 file

4
form412227001_01072025.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Cyclacel Pharmaceuticals, Inc.

CIK 0001130166

Entity typeother

Related Parties

1

filerCIK 0001253108

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 7:07 PM ET
Size: 4.8 KB

View on SEC.gov